Companies · Other

MedZed LLC

ATLANTA · Other

Diligence memoA one-page analyst read on MedZed LLC — recommendation, valuation, rhythm, risks.
$4.5M
Total raised · real
1
Rounds
0.8×
Latest step-up
Top 37%
Sector rank · raised
Series A
Latest stage · inferred · Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

MedZed LLC looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.58× the median modeled value of Series A Other companies in 2019–2021 (858 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.8 yr ago; this sector typically re-raises about every 11 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

MedZed LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.8 yr record
Peak capital year was 2021 with $10.5M across 2 filings.
Market position
ahead of 64% of Other peers
Capital scale is ahead of 64% of Other peers; modeled value is above 71% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Lower applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • Sector is still broad/Other, so operating comparables are weak.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2021: $10.5M across 2 filings.
  • Largest single filing was $6.0M on 2021-09-21.
  • Filing rows sum to $10.5M, while canonical raised total is $4.5M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other

MedZed LLC is one of 25008 Other companies tracked from ATLANTA. By capital raised it ranks mid-pack (ahead of 64% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
6
Investors (latest)
2021-09-21
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeries A · 2021-09-21 Raised $6.0M (real) Modeled valuation $63M (est)$6.0M$63MSeries A2021Series A · 2021-09-21 Raised $4.5M (real) Modeled valuation $47M (est)$4.5M$47MSeries A2021+$4.5MCumulative $10M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.0M · 2021
Series A extension$4.5M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$47.1M
Base estimate est.
$6.1M
Conservative case
$193.3M
Upside case
$20.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Series A · modeled $62.7M · 2021-09-212021Series A · modeled $47.1M · 2021-09-212021
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
55%
Survival probability
30% low · 75% high
1.35×/yr
Annual markup
1.70×/yr upside case
4.8 yr
Elapsed time used
4.8 yr actual, capped for stale marks
general
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
4.8 yr
On record since
2021
First round
2
Rounds on file
How it compares to the market

Benchmarked against 25008 companies in Other. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.2× above median
This company$4.5M
Sector median$2.0M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.8× of median
This company$4.5M
Sector median$5.7M
Modeled value — vs sector median (estimate, all stages) 2.7× above median
This company$47.1M
Sector median$17.7M

Raised more than 64% of sector peers (real $). Modeled value above 71% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #719 of 858.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)3901 Campbellton Rd., LLC · Series A Raised $15.0M · modeled $227.0M (est)No More Landfills Investment Group, LLC · Series A Raised $15.0M · modeled $227.0M (est)medpai group · Series A Raised $15.0M · modeled $227.0M (est)WestCap Bolt, LLC · Series A Raised $15.0M · modeled $227.0M (est)HBC Management Class B L.P. · Series A Raised $15.0M · modeled $226.3M (est)Globus Maritime Ltd · Series A Raised $27.4M · modeled $223.2M (est)Redwood Holding Group, LLC · Series A Raised $21.1M · modeled $222.5M (est)Sol de Janeiro Holdings, Inc. · Series A Raised $14.6M · modeled $220.6M (est)Patrick Partners LLC · Series A Raised $14.5M · modeled $219.4M (est)Concord Resources Holdings Ltd · Series A Raised $14.4M · modeled $218.2M (est)Bigstream Solutions, Inc. · Series A Raised $19.8M · modeled $216.3M (est)Engageli, Inc. · Series A Raised $14.5M · modeled $215.7M (est)MedZed LLC (this company) Raised $4.5M · modeled $47.1M (est)MedZed LLC
CompanyStageRaised · realValue · estvs peer med.
3901 Campbellton Rd., LLCSeries A$15.0M$227.0M2.81×
No More Landfills Investment Group, LLCSeries A$15.0M$227.0M2.81×
medpai groupSeries A$15.0M$227.0M2.81×
WestCap Bolt, LLCSeries A$15.0M$227.0M2.81×
HBC Management Class B L.P.Series A$15.0M$226.3M2.80×
Globus Maritime LtdSeries A$27.4M$223.2M2.76×
Redwood Holding Group, LLCSeries A$21.1M$222.5M2.75×
Sol de Janeiro Holdings, Inc.Series A$14.6M$220.6M2.73×
Patrick Partners LLCSeries A$14.5M$219.4M2.71×
Concord Resources Holdings LtdSeries A$14.4M$218.2M2.70×
Bigstream Solutions, Inc.Series A$19.8M$216.3M2.67×
Engageli, Inc.Series A$14.5M$215.7M2.67×
MedZed LLC this companySeries A$4.5M$47.1M0.58×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.0M2021-09-21$27.2M$62.7M90%
Series A$4.5M2021-09-21$20.5M$47.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.0M2021-09-21
    • First recorded raise — entered as Series A.
    • 23 investors on this round.
  2. Series A$4.5M2021-09-21
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 6 investors on this round.
Intelligence
Modeled next raise
$4.5M
Modeled next size est.range $4.5M$7.2M
0.8×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Adam Edwards Letson2021-09
Neil Edwards Solomon2021-09
Paul Edwards Schnell2021-09
Richard Edwards Hassett2021-09
Scott Edwards Schnell2021-09
Registry & provenance

MedZed LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1809968
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
NSF Bark, LLCOtherSeries A$4.5M$45.6Msame sector · same stage
Insurate, Inc.OtherSeries A$4.5M$47.2Msame sector · same stage
1246778 B.C. Ltd.OtherSeries A$4.5M$46.8Msame sector · same stage
Hk Lh LlcOtherSeries A$4.4M$45.8Msame sector · same stage
Vail Valley Portfolio, LLCOtherSeries A$4.4M$48.1Msame sector · same stage
Replai, Inc.OtherSeries A$4.6M$48.5Msame sector · same stage
OT Holding CorpOtherSeries A$4.6M$45.5Msame sector · same stage
Pause Group, Inc.OtherSeries A$4.7M$45.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
MedZed Holdings, LLCOtherSeed$29.0M93%
Medable Inc.Other Health CareSeries D+$5.4B83%
MedGeo Ventures, LLCOtherSeed$5.6M83%
MedVet Associates, LLCOtherSeries D+$20.5M83%
Medcare EnterprisesOtherSeed$25.8M82%
MedMama, LLCOtherSeed$18.5M82%
MedicaMetrix, LLCOtherSeed$45.1M81%
Med-X, Inc.OtherSeries A$32.5M81%
Frequently asked
How much funding has MedZed LLC raised?
MedZed LLC has raised approximately $4.5M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is MedZed LLC's estimated valuation?
Provath's modeled valuation for MedZed LLC is approximately $47.1M (modeled range $6.1M–$193.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is MedZed LLC at?
MedZed LLC's latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Sep 21.
What does MedZed LLC do and where is it based?
MedZed LLC operates in the Other sector, based in ATLANTA.
Explore related

See where MedZed LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at MedZed LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.